Kronox Lab Sciences Share Price
177.53+0.00 (-4.07%)
+23.72% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SOLARINDSNSE
PIDILITINDNSE
SRFNSE
FLUOROCHEMNSE
GODREJINDNSE
AETHERNSE
DEEPAKNTRNSE
DEEPAKFERTNSE
FINEORGNSE
KRONOX-BENSE
Kronox Lab Sciences Share Price
177.53+0.00 (-4.07%)
+23.72% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | 10% | 2% | 1% |
| - | 23% | 19% | 9% |
| - | - | - | 24% |
| 36% | 35% | 33% | 27% |
Peer Comparison
Symbol
SOLARINDS
PIDILITIND
SRF
FLUOROCHEM
NAVINFLUOR
GODREJIND
AETHER
DEEPAKNTR
DEEPAKFERT
FINEORG
KRONOX-BE
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 18,649 | ₹170574 Cr | 75.36 | 68.18 | 283.5 | ₹1678 Cr |
| 1,584.9 | ₹160623 Cr | 59.84 | 6.03 | 30.24 | ₹2449 Cr |
| 2,524.3 | ₹74490 Cr | 32.63 | 17.18 | 106.98 | ₹1835 Cr |
| 4,957 | ₹54764 Cr | 80.65 | 22.09 | 97.5 | ₹577 Cr |
| 10,203 | ₹52333 Cr | 57.47 | 52.48 | 208.91 | ₹664 Cr |
| 1,090.35 | ₹37074 Cr | 24.84 | 16.61 | 60.64 | ₹1241 Cr |
| 1,678.5 | ₹22515 Cr | 90.34 | 5.12 | 24.71 | ₹219 Cr |
| 1,547.8 | ₹21197 Cr | 19.96 | 29.15 | 96.58 | ₹551 Cr |
| 1,438 | ₹18369 Cr | 15.77 | 31.19 | 125.33 | ₹737 Cr |
| 5,495 | ₹16731 Cr | 34.73 | 49.62 | 176.69 | ₹417 Cr |
| 184.7 | ₹683 Cr | 24.09 | 1.74 | 8.21 | ₹28 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹27 Cr | ₹28 Cr | ₹26 Cr | ₹25 Cr | ₹26 Cr | ₹24 Cr | ₹26 Cr | ₹24 Cr | ₹25 Cr | ₹25 Cr | ₹22 Cr | ₹21 Cr | ₹21 Cr | ₹26 Cr | ₹21 Cr |
| ₹87 L | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹87 L | ₹91 L | ₹82 L | ₹36 L | ₹43 L | ₹83 L | ₹2 L | ₹49 L | ₹24 L | ₹14 L |
| ₹28 Cr | ₹30 Cr | ₹28 Cr | ₹26 Cr | ₹27 Cr | ₹25 Cr | ₹27 Cr | ₹25 Cr | ₹25 Cr | ₹26 Cr | ₹23 Cr | ₹21 Cr | ₹22 Cr | ₹26 Cr | ₹22 Cr |
| ₹19 Cr | ₹20 Cr | ₹17 Cr | ₹18 Cr | ₹17 Cr | ₹17 Cr | ₹19 Cr | ₹16 Cr | ₹16 Cr | ₹17 Cr | ₹15 Cr | ₹15 Cr | ₹16 Cr | ₹18 Cr | ₹18 Cr |
| ₹9 Cr | ₹10 Cr | ₹12 Cr | ₹9 Cr | ₹10 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹6 Cr | ₹6 Cr | ₹9 Cr | ₹4 Cr |
| ₹8 L | ₹3 L | ₹4 L | ₹4 L | ₹4 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹10,000 |
| ₹9 Cr | ₹10 Cr | ₹11 Cr | ₹9 Cr | ₹9 Cr | ₹8 Cr | ₹8 Cr | ₹9 Cr | ₹9 Cr | ₹8 Cr | ₹8 Cr | ₹6 Cr | ₹6 Cr | ₹8 Cr | ₹4 Cr |
| ₹6 Cr | ₹7 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹6 Cr | ₹7 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹4 Cr | ₹6 Cr | ₹2 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| — | — | — | — | — | — |
| ₹37 Cr | ₹37 Cr | ₹37 Cr | ₹37 Cr | ₹24 L | ₹24 L |
| ₹79 Cr | ₹53 Cr | ₹29 Cr | ₹8 Cr | ₹40 Cr | ₹27 Cr |
| ₹79 Cr | ₹53 Cr | ₹29 Cr | ₹8 Cr | ₹40 Cr | ₹27 Cr |
| ₹116 Cr | ₹90 Cr | ₹66 Cr | ₹45 Cr | ₹40 Cr | ₹27 Cr |
| ₹1 Cr | ₹0 | ₹0 | ₹0 | ₹47 L | ₹0 |
| -₹40 L | -₹40 L | -₹38 L | -₹34 L | -₹33 L | -₹24 L |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹2 Cr | ₹3 Cr |
| ₹2 L | ₹3 L | ₹2 L | ₹49 L | ₹52 L | ₹17 L |
| ₹63 L | -₹37 L | -₹36 L | ₹15 L | ₹2 Cr | ₹3 Cr |
| — | — | — | — | — | — |
| ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹8 Cr | ₹12 Cr | ₹7 Cr |
| ₹2 Cr | ₹80 L | ₹61 L | ₹56 L | ₹1 Cr | ₹1 Cr |
| ₹2 Cr | ₹62 L | ₹67 L | ₹64 L | ₹82 L | ₹26 L |
| ₹10 Cr | ₹9 Cr | ₹8 Cr | ₹9 Cr | ₹14 Cr | ₹8 Cr |
| ₹127 Cr | ₹98 Cr | ₹74 Cr | ₹54 Cr | ₹56 Cr | ₹37 Cr |
| ₹0 | ₹0 | ₹18 L | ₹0 | ₹0 | ₹0 |
| ₹2 Cr | ₹0 | ₹0 | ₹0 | ₹64 L | ₹1 L |
| — | — | — | — | — | — |
| ₹43 Cr | ₹40 Cr | ₹37 Cr | ₹26 Cr | ₹22 Cr | ₹18 Cr |
| ₹14 Cr | ₹12 Cr | ₹11 Cr | ₹10 Cr | ₹10 Cr | ₹9 Cr |
| ₹29 Cr | ₹28 Cr | ₹26 Cr | ₹16 Cr | ₹11 Cr | ₹9 Cr |
| ₹88 L | ₹76 L | ₹49 L | ₹0 | ₹0 | ₹40 L |
| ₹3 L | ₹3 L | ₹3 L | ₹3 L | ₹3 L | ₹3 L |
| ₹3 L | ₹3 L | ₹3 L | ₹3 L | ₹3 L | ₹3 L |
| ₹10 L | ₹10 L | ₹10 L | ₹7 L | ₹98 L | ₹2 Cr |
| ₹19 Cr | ₹6 Cr | ₹0 | ₹4 Cr | ₹0 | ₹0 |
| ₹48 Cr | ₹35 Cr | ₹27 Cr | ₹20 Cr | ₹12 Cr | ₹11 Cr |
| — | — | — | — | — | — |
| ₹8 Cr | ₹6 Cr | ₹9 Cr | ₹9 Cr | ₹8 Cr | ₹5 Cr |
| ₹21 Cr | ₹20 Cr | ₹18 Cr | ₹19 Cr | ₹26 Cr | ₹15 Cr |
| ₹49 Cr | ₹37 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr |
| ₹8 L | ₹9 L | ₹4 Cr | ₹77 L | ₹47 L | ₹45 L |
| ₹47 L | ₹27 L | ₹12 Cr | ₹2 Cr | ₹8 Cr | ₹3 Cr |
| ₹79 Cr | ₹63 Cr | ₹47 Cr | ₹34 Cr | ₹44 Cr | ₹26 Cr |
| ₹68 Cr | ₹55 Cr | ₹39 Cr | ₹25 Cr | ₹30 Cr | ₹18 Cr |
| ₹127 Cr | ₹98 Cr | ₹74 Cr | ₹54 Cr | ₹56 Cr | ₹37 Cr |
| ₹31 | ₹24 | ₹18 | ₹12 | ₹1,674 | ₹1,113 |
| ₹31 | ₹24 | ₹18 | ₹12 | ₹10 | ₹7 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| ₹37 Cr | ₹34 Cr | ₹29 Cr | ₹22 Cr | ₹18 Cr | ₹13 Cr |
| -₹1 Cr | -₹13 L | ₹54 L | ₹1 Cr | ₹2 Cr | ₹2 Cr |
| -₹2 Cr | ₹5 Cr | -₹4 Cr | ₹2 Cr | -₹7 Cr | -₹54 L |
| ₹34 Cr | ₹40 Cr | ₹25 Cr | ₹25 Cr | ₹14 Cr | ₹15 Cr |
| ₹24 Cr | ₹31 Cr | ₹17 Cr | ₹20 Cr | ₹9 Cr | ₹11 Cr |
| -₹24 Cr | -₹28 Cr | -₹17 Cr | -₹7 Cr | -₹8 Cr | -₹3 Cr |
| -₹36 L | -₹2 Cr | ₹0 | -₹13 Cr | -₹67 L | -₹7 Cr |
| -₹29 L | ₹45 L | ₹10 L | -₹33 L | ₹76 L | ₹1 Cr |
| ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹79 L |
| ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr |
Fundamental Ratios
Consolidated
Standalone

No results found
Kronox Lab Sciences Share Price
177.53+0.00 (-4.07%)
+23.72% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 6 out of 9 oscillators
RSI
38.81Sell
STOCH %K
2.56Buy
MACD Level(12,26)
-3.60Sell
Ultimate Oscillator
35.63Sell
Aroon Oscillator
18.00Sell
BOP
-0.85Sell
CCI
-166.61Buy
Williams %R
-97.44Buy
Momentum
-16.85Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 7 out of 9 moving averages
EMA 9
185.64Sell
SMA 9
186.95Sell
EMA 21
189.94Sell
SMA 21
190.27Sell
EMA 50
189.39Sell
SMA 50
193.57Sell
EMA 200
167.58Buy
SMA 200
153.82Buy
WMA 20
188.53Sell
Pivot
Pivot
Classic
Resistance 5
210.97
Resistance 4
204.52
Resistance 3
198.07
Resistance 2
191.62
Resistance 1
188.34
Pivot
185.17
Support 1
181.89
Support 2
178.72
Support 3
172.27
Support 4
165.82
Support 5
159.37
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Kronox Lab Sciences Share Price
177.53+0.00 (-4.07%)
+23.72% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 64.26% | 74.21% | 74.21% | 74.21% | 74.21% | 74.21% |
| 0.10% | 0.04% | 0.08% | 0.05% | 0.03% | 0.03% |
| 2.54% | 2.07% | 2.05% | 2.00% | 1.93% | 1.71% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 33.10% | 23.68% | 23.66% | 23.74% | 23.83% | 24.05% |
Bulk & block deals
Name
Jump Trading Financial India Private Limited
Musigma Securities
Clt Research Tech Private Ltd
Ramdoot Realtors Pvt Ltd
Silverleaf Capital Services Private Limited
Puma Securities
Vinsul Makardi Ltd
J4s Financial Solutions Llp
Microcurves Trading Private Limited
Junomoneta Finsol Private Limited
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 21 Aug 2026 | Purchase | 6.03 Cr | ₹209.61 | 2.88 L | Bulk | 0.775679 | NSE |
| 21 Aug 2026 | Purchase | 6.07 Cr | ₹210.97 | 2.88 L | Bulk | 0.775251 | NSE |
| 21 Aug 2026 | Purchase | 8.78 Cr | ₹209.82 | 4.18 L | Bulk | 1.127418 | NSE |
| 21 Aug 2026 | Purchase | 8.81 Cr | ₹217.89 | 4.04 L | Bulk | 1.089821 | NSE |
| 21 Aug 2026 | Purchase | 4.70 Cr | ₹205.69 | 2.29 L | Bulk | 0.616262 | NSE |
| 21 Aug 2026 | Purchase | 4.80 Cr | ₹208.66 | 2.30 L | Bulk | 0.620305 | NSE |
| 21 Aug 2026 | Purchase | 5.26 Cr | ₹210.05 | 2.50 L | Bulk | 0.674442 | NSE |
| 21 Aug 2026 | Purchase | 4.94 Cr | ₹208.34 | 2.37 L | Bulk | 0.639338 | NSE |
| 21 Aug 2026 | Purchase | 19.07 Cr | ₹209.54 | 9.10 L | Bulk | 2.452668 | NSE |
| 21 Aug 2026 | Purchase | 16.55 Cr | ₹209.22 | 7.91 L | Bulk | 2.132309 | NSE |
Insider trading & SAST
Client name
Indo Borax & Chemicals Limited
Indo Borax & Chemicals Limited
Mr. Pritesh Ramani
Mr. Ketan Ramani
Mr. Jogindersingh Jaswal
Pritesh V. Ramani
Indo Borax & Chemicals Limited
Ketan Ramani
Jogindersingh Jaswal
Indo Borax & Chemicals Limited
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19 Nov 2026 | Promoter | — | 50.262613 | 64.26 | 337.28 Cr | ₹180.85 | 1.86 Cr | 17 Nov 2026 | Pledge Creation | 2,38,44,000 | Insider Trading | — | Equity |
| 07 Nov 2026 | Promoter | — | 14.004716 | 64.26 | 53.64 Cr | ₹103.22 | 51.96 L | 03 Nov 2026 | Pledge Creation | 2,38,44,000 | Insider Trading | — | Equity |
| 01 Oct 2026 | Promoter | Disposal | 18.087538 | 3.31 | 69.27 Cr | ₹103.22 | 67.11 L | 29 Sep 2026 | Others | 12,30,000 | Insider Trading | — | Equity |
| 01 Oct 2026 | Promoter | Disposal | 23.087538 | 3.31 | 88.42 Cr | ₹103.22 | 85.66 L | 29 Sep 2026 | Others | 12,30,000 | Insider Trading | — | Equity |
| 01 Oct 2026 | Promoter | Disposal | 23.087538 | 3.31 | 88.42 Cr | ₹103.22 | 85.66 L | 29 Sep 2026 | Others | 12,30,000 | Insider Trading | — | Equity |
| 30 Sep 2026 | Promoter | Disposal | 18.09 | 3.32 | 0 | — | 67.11 L | 30 Sep 2026 | Sale of Shares - offmarket | 12,30,000 | SAST | 29(2) | Equity Shares |
| 30 Sep 2026 | Other | Acquisition | 18.09 | 41.18 | 0 | — | 67.11 L | 30 Sep 2026 | Acquisition of shares - offmarket | 1,52,77,600 | SAST | 29(2) | Equity Shares |
| 30 Sep 2026 | Promoter | Disposal | 23.09 | 3.32 | 0 | — | 85.66 L | 30 Sep 2026 | Sale of Shares - offmarket | 12,30,000 | SAST | 29(2) | Equity Shares |
| 30 Sep 2026 | Promoter | Disposal | 23.09 | 3.32 | 0 | — | 85.66 L | 30 Sep 2026 | Sale of Shares - offmarket | 12,30,000 | SAST | 29(2) | Equity Shares |
| 30 Sep 2026 | Other | Acquisition | 23.09 | 23.09 | 0 | — | 85.66 L | 30 Sep 2026 | Acquisition of shares - offmarket | 85,66,400 | SAST | 29(1) | Equity Shares |
Kronox Lab Sciences Share Price
177.53+0.00 (-4.07%)
+23.72% past 1 Year
Kronox Lab Sciences is a bulk manufacturer of high purity fine chemicals, in compliance with Reagent, Pharmacopoeia and various Food Grade standards, for the pharmaceutical, nutraceutical, veterinary, food, chemical analysis
Corporate Actions
Date
Type
Details
Company details
Kronox Lab Sciences Share Price
177.53+0.00 (-4.07%)
+23.72% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Kronox Lab Sciences Share Price
177.53+0.00 (-4.07%)
+23.72% past 1 Year
News
1 of 20
Stock NewsKRONOX14 Oct 2026
Kronox Lab Sciences has received approval to acquire a 5,000 square metre manufacturing plant in Dahej SEZ from Axiom Chemicals. The proposed transaction will be funded through the company’s internal earnings, avoiding additional debt or external financing based on the available information.
The acquisition is intended to increase Kronox Lab Sciences’ manufacturing capacity and strengthen its operating footprint in specialty chemicals. Additional capacity could support future volume growth, improve production flexibility and expand the company’s ability to serve customers across pharmaceutical, nutraceutical and other end-user industries. The available announcement does not specify the transaction value, commissioning timeline, incremental capacity, expected revenue contribution or earnings impact.
The development is a company-specific expansion initiative and represents a positive operational trigger, although the near-term financial impact remains unquantified.
Kronox Lab Sciences Appoints Shashikant Bharuka As Chief Financial Officer
Stock NewsKRONOX29 Sept 2026
Kronox Lab Sciences has appointed Shashikant Bharuka as its new Chief Financial Officer. The management change follows the departure of Samir Gadhiya from the CFO position, while he will continue with the company in a senior management role.
The appointment is part of a broader management restructuring after promoters transferred a 64.26% stake to Indo Borax. Suresh Kalra has been appointed Managing Director and Chief Executive Officer, and Sunil Malhotra has been appointed Whole-time Director. The company has not disclosed any immediate change to earnings, leverage, production capacity, or market share from the CFO appointment.
Kronox Lab Sciences reports Profit after tax of 8.00 Crores, in the March 2026 quarter
ResultKRONOX21 May 2026
NULL
Kronox Lab Sciences reports Profit after tax of 6.59 Crores, in the December 2025 quarter
ResultKRONOX14 Feb 2026
NULL
Kronox Lab Sciences reports Profit after tax of 6.68 Crores, in the September 2025 quarter
ResultKRONOX11 Nov 2025
NULL
Kronox Lab Sciences Q2 FY26: Net Profit and Revenue Register Modest Year-on-Year Growth
ResultKRONOX11 Nov 2025
Kronox Lab Sciences reported its results for the second quarter, recording a standalone net profit of Rs 6.70 crores versus Rs 6.50 crores in the corresponding quarter last year. Revenue for the quarter stood at Rs 25.50 crores compared to Rs 24.80 crores year-on-year, indicating stable operational performance with incremental growth.
The company remains debt-free and continues to maintain robust financial health, as indicated by a consistent return on equity profile and healthy cash levels. Kronox Lab Sciences is engaged in the manufacture of high-purity fine, inorganic, phosphate, and metallic chemicals and has demonstrated good compounded profit and sales growth over multiple periods. The Q2 numbers reflect a continuation of this trajectory, albeit with modest gains indicative of steady business momentum.
No management commentary or segmental details were available, and figures for EBITDA, margins, or guidance were not disclosed in the reported context. There were no market-moving surprises or significant deviations from recent quarterly trends.
The company remains debt-free and continues to maintain robust financial health, as indicated by a consistent return on equity profile and healthy cash levels. Kronox Lab Sciences is engaged in the manufacture of high-purity fine, inorganic, phosphate, and metallic chemicals and has demonstrated good compounded profit and sales growth over multiple periods. The Q2 numbers reflect a continuation of this trajectory, albeit with modest gains indicative of steady business momentum.
No management commentary or segmental details were available, and figures for EBITDA, margins, or guidance were not disclosed in the reported context. There were no market-moving surprises or significant deviations from recent quarterly trends.
Kronox Lab Sciences receives Central Government environmental clearance for Dahej Unit-IV expansion.
Stock NewsKRONOX10 Nov 2025
Kronox Lab Sciences Limited has obtained final environmental clearance from the Central Government for construction of its Unit-IV facility at Dahej, marking the completion of all statutory requirements for this project. This approval enables the company to formally commence construction activities at the Dahej site.
The clearance, disclosed through regulatory notices and exchange filings, represents a pivotal step in Kronox Lab Sciences' expansion plans, following earlier approvals from relevant authorities. The company communicated that the environmental clearance was the last pending major regulatory step, as updated during its annual general meeting on August 18, 2025.
The new facility is expected to strengthen Kronox Lab Sciences' production capabilities, supporting its business growth objectives in the specialty chemicals and lab sciences sector. The development aligns with the company’s strategy of sustainable compliance, regulatory transparency, and operational expansion. While this green signal reflects progress in project execution, its eventual financial impact will depend on future operational outcomes and market conditions.
Recent share price movement has remained modest, evidencing routine trading volumes on both NSE and BSE around this development. All communications related to the approval have adhered to SEBI (Listing Obligations and Disclosure Requirements) and other statutory regulations.
Key tags: Kronox Lab Sciences Limited, Specialty Chemicals, Dahej, Unit-IV, Central Government Approval, SEBI regulations, Environmental Clearance, Expansion Plan, Corporate Action.
The clearance, disclosed through regulatory notices and exchange filings, represents a pivotal step in Kronox Lab Sciences' expansion plans, following earlier approvals from relevant authorities. The company communicated that the environmental clearance was the last pending major regulatory step, as updated during its annual general meeting on August 18, 2025.
The new facility is expected to strengthen Kronox Lab Sciences' production capabilities, supporting its business growth objectives in the specialty chemicals and lab sciences sector. The development aligns with the company’s strategy of sustainable compliance, regulatory transparency, and operational expansion. While this green signal reflects progress in project execution, its eventual financial impact will depend on future operational outcomes and market conditions.
Recent share price movement has remained modest, evidencing routine trading volumes on both NSE and BSE around this development. All communications related to the approval have adhered to SEBI (Listing Obligations and Disclosure Requirements) and other statutory regulations.
Key tags: Kronox Lab Sciences Limited, Specialty Chemicals, Dahej, Unit-IV, Central Government Approval, SEBI regulations, Environmental Clearance, Expansion Plan, Corporate Action.
Kronox Lab Science: Q1 Sl Net Profit 6.30 Crores Rupees Vs 63 (Yoy) || Q1 Revenue 24.30 Crores Rupees Vs 26.10 Crores (Yoy)
ResultKRONOX11 Aug 2025
Kronox Lab Science: Q1 Sl Net Profit 6.30 Crores Rupees Vs 63 (Yoy) || Q1 Revenue 24.30 Crores Rupees Vs 26.10 Crores (Yoy)
Kronox Lab Sciences - Quaterly Results
ResultKRONOX11 Aug 2025
NULL
Kronox Lab Sciences reports Profit after tax of 6.28 Crores, in the June 2025 quarter
ResultKRONOX11 Aug 2025
NULL
Kronox Lab Sciences - Quaterly Results
ResultKRONOX11 Aug 2025
NULL
Kronox Lab Sciences - Quaterly Results
ResultKRONOX11 Aug 2025
NULL
Kronox Lab Sciences informs about press release
Stock NewsKRONOX28 Jul 2025
NULL
Kronox Lab Sciences informs about AGM
Stock NewsKRONOX26 Jul 2025
NULL
Kronox Lab Sciences informs about appointment of secretarial audior
Stock NewsKRONOX26 Jul 2025
NULL
Kronox Lab Sciences - Quaterly Results
ResultKRONOX22 May 2025
NULL
Kronox Lab Sciences reports Profit after tax of 6.32 Crores, in the March 2025 quarter
ResultKRONOX22 May 2025
NULL
Kronox Lab Sciences - Quaterly Results
ResultKRONOX22 May 2025
NULL
Kronox Lab Sciences - Quaterly Results
ResultKRONOX22 May 2025
NULL
Kronox Lab Sciences: Q4 Ebitda 7.70 Crores Rupees Vs 7.90 Crores (Yoy) || Q4 Ebitda Margin 29.62% Vs 35.44% (Yoy)
ResultKRONOX22 May 2025
Kronox Lab Sciences: Q4 Ebitda 7.70 Crores Rupees Vs 7.90 Crores (Yoy) || Q4 Ebitda Margin 29.62% Vs 35.44% (Yoy)

